*Intestinal Microbiomics in Physiological and Pathological Conditions DOI: http://dx.doi.org/10.5772/intechopen.110642*

in fecal microbiota composition in children may predict overweight. The American Journal of Clinical Nutrition. 2008;**87**(3):534-538. DOI: 10.1093/ ajcn/87.3.534

[174] Di Domenico M, Pinto F, Quagliuolo L, Contaldo M, Settembre G, Romano A, et al. The role of oxidative stress and hormones in controlling obesity. Frontiers in Endocrinology (Lausanne). 2019;**10**:540. DOI: 10.3389/ fendo.2019.00540

[175] Turnbaugh PJ, Bäckhed F, Fulton L, Gordon JI. Diet-induced obesity is linked to marked but reversible alterations in the mouse distal gut microbiome. Cell Host & Microbe. 2008;**3**(4):213-223. DOI: 10.1016/j.chom.2008.02.015

[176] Davis CD. The gut microbiome and its role in obesity. Nutrition Today. 2016;**51**(4):167-174. DOI: 10.1097/ nt.0000000000000167

[177] Turnbaugh PJ, Ridaura VK, Faith JJ, Rey FE, Knight R, Gordon JI. The effect of diet on the human gut microbiome: A metagenomic analysis in humanized gnotobiotic mice. Science Translational Medicine. 2009;**1**(6):6ra14. DOI: 10.1126/ scitranslmed.3000322

[178] Wu GD, Chen J, Hoffmann C, Bittinger K, Chen YY, Keilbaugh SA, et al. Linking long-term dietary patterns with gut microbial enterotypes. Science. 2011;**334**(6052):105-108. DOI: 10.1126/ science.1208344

[179] Chen J, Thomsen M, Vitetta L. Interaction of gut microbiota with dysregulation of bile acids in the pathogenesis of nonalcoholic fatty liver disease and potential therapeutic implications of probiotics. Journal of Cellular Biochemistry. 2019;**120**(3):2713-2720. DOI: 10.1002/ jcb.27635

[180] Pols TW, Nomura M, Harach T, Lo Sasso G, Oosterveer MH, Thomas C, et al. TGR5 activation inhibits atherosclerosis by reducing macrophage inflammation and lipid loading. Cell Metabolism. 2011;**14**(6):747-757. DOI: 10.1016/j.cmet.2011.11.006

[181] Maruvada P, Leone V, Kaplan LM, Chang EB. The human microbiome and obesity: Moving beyond associations. Cell Host & Microbe. 2017;**22**(5):589- 599. DOI: 10.1016/j.chom.2017.10.005

[182] Chassaing B, Ley RE, Gewirtz AT. Intestinal epithelial cell toll-like receptor 5 regulates the intestinal microbiota to prevent low-grade inflammation and metabolic syndrome in mice. Gastroenterology. 2014;**147**(6):1363-77. e17. DOI: 10.1053/j.gastro.2014.08.033

[183] Sonnenburg ED, Smits SA, Tikhonov M, Higginbottom SK, Wingreen NS, Sonnenburg JL. Dietinduced extinctions in the gut microbiota compound over generations. Nature. 2016;**529**(7585):212-215. DOI: 10.1038/ nature16504

[184] Helmink BA, Khan MAW, Hermann A, Gopalakrishnan V, Wargo JA. The microbiome, cancer, and cancer therapy. Nature Medicine. 2019;**25**(3):377-388. DOI: 10.1038/ s41591-019-0377-7

[185] Murphy EF, Cotter PD, Healy S, Marques TM, O'Sullivan O, Fouhy F, et al. Composition and energy harvesting capacity of the gut microbiota: relationship to diet, obesity and time in mouse models. Gut. 2010;**59**(12):1635-1642. DOI: 10.1136/ gut.2010.215665

[186] Petersen C, Bell R, Klag KA, Lee SH, Soto R, Ghazaryan A, et al. T cellmediated regulation of the microbiota protects against obesity. Science.

2019;**365**(6451):eaat9351. DOI: 10.1126/ science.aat9351

[187] den Besten G, Bleeker A, Gerding A, van Eunen K, Havinga R, van Dijk TH, et al. Short-chain fatty acids protect against high-fat diet-induced obesity via a PPARγ-dependent switch from lipogenesis to fat oxidation. Diabetes. 2015;**64**(7):2398-2408. DOI: 10.2337/ db14-1213

[188] Wlodarska M, Thaiss CA, Nowarski R, Henao-Mejia J, Zhang JP, Brown EM, et al. NLRP6 inflammasome orchestrates the colonic host-microbial interface by regulating goblet cell mucus secretion. Cell. 2014;**156**(5):1045-1059. DOI: 10.1016/j.cell.2014.01.026

[189] Cani PD, Delzenne NM. The gut microbiome as therapeutic target. Pharmacology & Therapeutics. 2011;**130**(2):202-212. DOI: 10.1016/j. pharmthera.2011.01.012

[190] Turnbaugh PJ, Ley RE, Mahowald MA, Magrini V, Mardis ER, Gordon JI. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature. 2006;**444**(7122):1027-1031. DOI: 10.1038/nature05414

[191] Le Chatelier E, Nielsen T, Qin J, Prifti E, Hildebrand F, Falony G, et al. Richness of human gut microbiome correlates with metabolic markers. Nature. 2013;**500**(7464):541-546. DOI: 10.1038/nature12506

[192] Shajib MS, Khan WI. The role of serotonin and its receptors in activation of immune responses and inflammation. Acta Physiologica (Oxford, England). 2015;**213**(3):561-574. DOI: 10.1111/ apha.12430

[193] Sandhu KV, Sherwin E, Schellekens H, Stanton C, Dinan TG, Cryan JF. Feeding the microbiotagut-brain axis: Diet, microbiome, and neuropsychiatry. Translational Research. 2017;**179**:223-244. DOI: 10.1016/j. trsl.2016.10.002

[194] Delzenne NM, Cani PD, Daubioul C, Neyrinck AM. Impact of inulin and oligofructose on gastrointestinal peptides. The British Journal of Nutrition. 2005;**93**(Suppl 1):S157-S161. DOI: 10.1079/bjn20041342

[195] Torres-Fuentes C, Schellekens H, Dinan TG, Cryan JF. A natural solution for obesity: Bioactives for the prevention and treatment of weight gain. A review. Nutritional Neuroscience. 2015;**18**(2):49-65. DOI: 10.1179/1476830513y.0000000099

[196] Cox LM, Blaser MJ. Antibiotics in early life and obesity. Nature Reviews Endocrinology. 2015;**11**(3):182-190. DOI: 10.1038/nrendo.2014.210

[197] Salazar J, Angarita L, Morillo V, Navarro C, Martínez MS, Chacín M, et al. Microbiota and diabetes mellitus: Role of lipid mediators. Nutrients. 2020;**12**(10):3039. DOI: 10.3390/ nu12103039

[198] Schwartz SS, Epstein S, Corkey BE, Grant SF, Gavin JR 3rd, Aguilar RB. The time is right for a new classification system for diabetes: Rationale and implications of the β-cell-centric classification schema. Diabetes Care. 2016;**39**(2):179-186. DOI: 10.2337/ dc15-1585

[199] Zozulinska D, Wierusz-Wysocka B. Type 2 diabetes mellitus as inflammatory disease. Diabetes Research and Clinical Practice. 2006;**74**(2):98-107. DOI: 10.1016/j.diabres.2006.06.007

[200] Roohi A, Tabrizi M, Abbasi F, Ataie-Jafari A, Nikbin B, Larijani B, *Intestinal Microbiomics in Physiological and Pathological Conditions DOI: http://dx.doi.org/10.5772/intechopen.110642*

et al. Serum IL-17, IL-23, and TGF-β levels in type 1 and type 2 diabetic patients and age-matched healthy controls. BioMed Research International. 2014;**2014**:718946. DOI: 10.1155/2014/718946

[201] Abdel-Moneim A, Bakery HH, Allam G. The potential pathogenic role of IL-17/Th17 cells in both type 1 and type 2 diabetes mellitus. Biomedicine & Pharmacotherapy. 2018;**101**:287-292. DOI: 10.1016/j.biopha.2018.02.103

[202] Zhang L, Chu J, Hao W, Zhang J, Li H, Yang C, et al. Gut microbiota and type 2 diabetes mellitus: Association, mechanism, and translational applications. Mediators of Inflammation. 2021;**2021**:5110276. DOI: 10.1155/2021/5110276

[203] Huang X, Yan D, Xu M, Li F, Ren M, Zhang J, et al. Interactive association of lipopolysaccharide and free fatty acid with the prevalence of type 2 diabetes: A community-based cross-sectional study. Journal of Diabetes Investigation. 2019;**10**(6):1438-1446. DOI: 10.1111/ jdi.13056

[204] Gomes JMG, Costa JA, Alfenas RCG. Metabolic endotoxemia and diabetes mellitus: A systematic review. Metabolism. 2017;**68**:133-144. DOI: 10.1016/j.metabol.2016.12.009

[205] Matheus VA,

Monteiro L, Oliveira RB, Maschio DA, Collares-Buzato CB. Butyrate reduces high-fat diet-induced metabolic alterations, hepatic steatosis and pancreatic beta cell and intestinal barrier dysfunctions in prediabetic mice. Experimental Biology and Medicine (Maywood NJ). 2017;**242**(12):1214-1226. DOI: 10.1177/1535370217708188

[206] Larsen N, Vogensen FK, van den Berg FW, Nielsen DS, Andreasen AS,

Pedersen BK, et al. Gut microbiota in human adults with type 2 diabetes differs from non-diabetic adults. PLoS One. 2010;**5**(2):e9085. DOI: 10.1371/journal. pone.0009085

[207] Endesfelder D, Engel M, Davis-Richardson AG, Ardissone AN, Achenbach P, Hummel S, et al. Towards a functional hypothesis relating anti-islet cell autoimmunity to the dietary impact on microbial communities and butyrate production. Microbiome. 2016;**4**:17. DOI: 10.1186/s40168-016-0163-4
